Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apertio is a specialized healthcare technology company that provides a comprehensive end-to-end SaaS platform for clinical trial transparency and disclosure. Based in London, the company assists pharmaceutical and biotechnology organizations in navigating the complex global regulatory landscape, including compliance with FDAAA 801 and the EU Clinical Trials Regulation (EU CTR). The Apertio platform automates the tracking, management, and submission of clinical trial data to various global registries, ensuring that sponsors meet mandatory disclosure deadlines. By streamlining workflows and reducing the risk of non-compliance, Apertio supports the industry's efforts to maintain public trust through transparent and timely data sharing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apertio.